Compare NCNA & MTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NCNA | MTR |
|---|---|---|
| Founded | 1997 | 1979 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.6M | 8.8M |
| IPO Year | 2017 | N/A |
| Metric | NCNA | MTR |
|---|---|---|
| Price | $3.72 | $4.61 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 65.1K | 2.7K |
| Earning Date | 11-13-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 4.44% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.23 |
| Revenue | N/A | ★ $623,288.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $20.59 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.78 | $4.29 |
| 52 Week High | $330.00 | $10.42 |
| Indicator | NCNA | MTR |
|---|---|---|
| Relative Strength Index (RSI) | 44.93 | 45.13 |
| Support Level | $4.10 | $4.58 |
| Resistance Level | $4.55 | $4.80 |
| Average True Range (ATR) | 0.28 | 0.11 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 7.06 | 19.36 |
NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States.
Mesa Royalty Trust holds net overriding royalty interests in various oil and gas properties located in the: Hugoton field of Kansas, San Juan Basin field of New Mexico, and San Juan Basin Field of Colorado.